Precision Capital for
Commercial Healthcare
We deploy growth equity exclusively into commercial-stage healthcare companies where regulatory approval has been achieved but market leadership requires operational infrastructure.
The healthcare industry produces thousands of clinically validated technologies each year. Fewer than 10% achieve meaningful commercial scale.
The constraint is rarely the product. It is the absence of dedicated commercialization infrastructure, market access, and operational execution capability. Eckuity Capital was built to close this gap.
Three verticals.
One conviction.
We invest where deep healthcare knowledge creates an asymmetric advantage: sectors where operational infrastructure is the primary determinant of commercial success.

Scaling Approved Medical Technologies
Commercial-stage medical device companies with regulatory clearance (510(k), PMA, CE Mark), demonstrated clinical utility, and scalable go-to-market strategies addressing large, underserved patient populations.

Transforming Healthcare Delivery
Healthcare technology platforms with product-market fit, enterprise adoption, and multi-year contracts transforming clinical workflows, population health management, and operational efficiency at scale.

Enabling the Ecosystem
Contract research, specialty pharma services, and clinical infrastructure companies that power the broader healthcare value chain with deep technical moats and capital-efficient growth profiles.
"The gap between a great product and a great company is almost always an infrastructure gap, not a technology gap."
Disciplined criteria.
Rigorous execution.
Capital is a commodity.
Infrastructure is not.
Most healthcare investors provide capital and board seats. We provide capital, board seats, and a fully operational commercialization platform, creating value that pure financial investors cannot replicate.
Proprietary Sourcing Network
Off-market deal flow through our network of 100+ hospital systems, clinical KOLs, and strategic partners across 38 markets.
Operational Commercialization
Through Nettwork Holdings, we deploy dedicated sales teams, market access infrastructure, and operational expertise directly into portfolio companies.
Clinical Intelligence
Our team includes physicians, PhDs, and healthcare operators who evaluate clinical utility, regulatory pathways, and market adoption with institutional rigor.
Disciplined Portfolio Construction
Concentrated portfolio of 12–15 companies per fund, with active board representation and hands-on value creation across every investment.
Explore our approach to value creation.
How we transform commercial-stage companies into category leaders.
